During the past decade, CHU Andre VESALE conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Andre VESALE" #1 sponsor was "Henogen" with 4 trials, followed by "Centre Hospitalier Departemental Vendee" with 3 trials sponsored, "European Lung Cancer Working Party" with 2 trials sponsored, "Chiesi SA/NV" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Andre VESALE" #1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator, "Ministry of Health, France" with 3 trials as a collaborator, "University Hospital, Tours" with 3 trials as a collaborator and "URC Eco Ile de France" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CHU Andre VESALE" are "Hepatitis B" (4 trials), "Ventilator-associated Pneumonia" (3 trials), "CML" (1 trials), "Chronic Myeloid Leukemia" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "CHU Andre VESALE" in a lesser frequency.

Most popular intervention types in "CHU Andre VESALE" are "Biological" (4 trials), "Device" (3 trials), "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Endotracheal tubes allowing SSD" (3 trials), "Endotracheal tubes not allowing SSD" (3 trials), "HBVAXPRO vaccine" (2 trials), "Concomitant Chemoradiotherapy - Radiotherapy 66 Gy, Cisplatin, and Docetaxel" (1 trials) and "Concomitant Radiochemotherapy - Radiotherapy 66 Gy, Cisplatin, and Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Andre VESALE" are 13 trials for "All" genders.

Currently, there are NaN active trials in "CHU Andre VESALE". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in CHU Andre VESALE, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Andre VESALE, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".